Our Chief Scientific Officer and Co-Founder here at Deep Lens, TJ Bowen, recently wrote this article for The Association of Clinical Research Professionals.
Breaking Down Barriers to Oncology Clinical Trial Enrollment Via Artificial Intelligence
Technology is successfully disrupting many industries — but can it help with the systemic challenges of clinical trial recruitment?
It is estimated that less than 5% of eligible adult patients enroll in clinical trials. This is an extremely small percentage and, given that approximately 15,000 oncology trials are actively recruiting patients, it means that there are not enough patients available.
Discover how AI could transform the clinical trial recruitment process: